vs

Side-by-side financial comparison of CME Group (CME) and Sunrun Inc. (RUN). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.2B, roughly 1.6× Sunrun Inc.). Sunrun Inc. runs the higher net margin — 8.9% vs 0.1%, a 8.9% gap on every dollar of revenue. On growth, Sunrun Inc. posted the faster year-over-year revenue change (123.5% vs 14.5%). Over the past eight quarters, Sunrun Inc.'s revenue compounded faster (59.0% CAGR vs 10.8%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Sunrun Inc. is an American provider of photovoltaic systems and battery energy storage products, primarily for residential customers. The company was established in 2007 and is headquartered in San Francisco, California.

CME vs RUN — Head-to-Head

Bigger by revenue
CME
CME
1.6× larger
CME
$1.9B
$1.2B
RUN
Growing faster (revenue YoY)
RUN
RUN
+109.0% gap
RUN
123.5%
14.5%
CME
Higher net margin
RUN
RUN
8.9% more per $
RUN
8.9%
0.1%
CME
Faster 2-yr revenue CAGR
RUN
RUN
Annualised
RUN
59.0%
10.8%
CME

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CME
CME
RUN
RUN
Revenue
$1.9B
$1.2B
Net Profit
$1.2M
$103.6M
Gross Margin
Operating Margin
0.1%
8.4%
Net Margin
0.1%
8.9%
Revenue YoY
14.5%
123.5%
Net Profit YoY
20.7%
103.7%
EPS (diluted)
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
RUN
RUN
Q1 26
$1.9B
Q4 25
$1.6B
$1.2B
Q3 25
$1.5B
$724.6M
Q2 25
$1.7B
$569.3M
Q1 25
$1.6B
$504.3M
Q4 24
$1.5B
$518.5M
Q3 24
$1.6B
$537.2M
Q2 24
$1.5B
$523.9M
Net Profit
CME
CME
RUN
RUN
Q1 26
$1.2M
Q4 25
$1.2B
$103.6M
Q3 25
$908.0M
$16.6M
Q2 25
$1.0B
$279.8M
Q1 25
$956.2M
$50.0M
Q4 24
$874.6M
$-2.8B
Q3 24
$912.8M
$-83.8M
Q2 24
$883.2M
$139.1M
Operating Margin
CME
CME
RUN
RUN
Q1 26
0.1%
Q4 25
61.8%
8.4%
Q3 25
63.3%
0.5%
Q2 25
66.7%
-19.7%
Q1 25
67.5%
-22.8%
Q4 24
62.1%
-628.0%
Q3 24
64.6%
-23.8%
Q2 24
65.3%
-24.4%
Net Margin
CME
CME
RUN
RUN
Q1 26
0.1%
Q4 25
71.7%
8.9%
Q3 25
59.1%
2.3%
Q2 25
60.6%
49.1%
Q1 25
58.2%
9.9%
Q4 24
57.3%
-542.7%
Q3 24
57.6%
-15.6%
Q2 24
57.6%
26.5%
EPS (diluted)
CME
CME
RUN
RUN
Q1 26
Q4 25
$3.24
$0.38
Q3 25
$2.49
$0.06
Q2 25
$2.81
$1.07
Q1 25
$2.62
$0.20
Q4 24
$2.40
$-12.59
Q3 24
$2.50
$-0.37
Q2 24
$2.42
$0.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
RUN
RUN
Cash + ST InvestmentsLiquidity on hand
$2.4B
Total DebtLower is stronger
$3.4B
$14.7B
Stockholders' EquityBook value
$3.1B
Total Assets
$202.0B
$22.6B
Debt / EquityLower = less leverage
4.69×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
RUN
RUN
Q1 26
$2.4B
Q4 25
$4.5B
Q3 25
$2.6B
Q2 25
$2.1B
Q1 25
$1.5B
Q4 24
$3.0B
Q3 24
$2.4B
Q2 24
$1.9B
Total Debt
CME
CME
RUN
RUN
Q1 26
$3.4B
Q4 25
$14.7B
Q3 25
$14.6B
Q2 25
$14.0B
Q1 25
$13.6B
Q4 24
$12.9B
Q3 24
$12.5B
Q2 24
$12.0B
Stockholders' Equity
CME
CME
RUN
RUN
Q1 26
Q4 25
$28.7B
$3.1B
Q3 25
$28.2B
$3.0B
Q2 25
$27.7B
$2.9B
Q1 25
$27.0B
$2.6B
Q4 24
$26.5B
$2.6B
Q3 24
$28.2B
$5.3B
Q2 24
$27.6B
$5.4B
Total Assets
CME
CME
RUN
RUN
Q1 26
$202.0B
Q4 25
$198.4B
$22.6B
Q3 25
$187.1B
$22.2B
Q2 25
$179.9B
$21.2B
Q1 25
$157.8B
$20.4B
Q4 24
$137.4B
$19.9B
Q3 24
$137.8B
$22.1B
Q2 24
$123.4B
$21.4B
Debt / Equity
CME
CME
RUN
RUN
Q1 26
Q4 25
4.69×
Q3 25
4.90×
Q2 25
4.80×
Q1 25
5.19×
Q4 24
5.05×
Q3 24
2.36×
Q2 24
2.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
RUN
RUN
Operating Cash FlowLast quarter
$96.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.94×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
RUN
RUN
Q1 26
Q4 25
$1.1B
$96.9M
Q3 25
$968.1M
$-121.5M
Q2 25
$1.1B
$-292.7M
Q1 25
$1.1B
$-104.2M
Q4 24
$1.0B
$-258.4M
Q3 24
$1.0B
$-156.2M
Q2 24
$776.9M
$-208.5M
Free Cash Flow
CME
CME
RUN
RUN
Q1 26
Q4 25
$1.1B
Q3 25
$949.7M
Q2 25
$1.0B
Q1 25
$1.1B
Q4 24
$991.7M
Q3 24
$973.2M
$-156.4M
Q2 24
$758.7M
FCF Margin
CME
CME
RUN
RUN
Q1 26
Q4 25
66.8%
Q3 25
61.8%
Q2 25
61.5%
Q1 25
67.1%
Q4 24
65.0%
Q3 24
61.4%
-29.1%
Q2 24
49.5%
Capex Intensity
CME
CME
RUN
RUN
Q1 26
Q4 25
2.0%
Q3 25
1.2%
Q2 25
1.1%
Q1 25
0.9%
Q4 24
1.7%
Q3 24
1.9%
0.0%
Q2 24
1.2%
Cash Conversion
CME
CME
RUN
RUN
Q1 26
Q4 25
0.96×
0.94×
Q3 25
1.07×
-7.33×
Q2 25
1.03×
-1.05×
Q1 25
1.17×
-2.08×
Q4 24
1.16×
Q3 24
1.10×
Q2 24
0.88×
-1.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

RUN
RUN

Products$692.3M60%
Customer Agreements$435.2M38%
Manufactured Product Other$56.7M5%
Incentives$31.3M3%

Related Comparisons